Patents by Inventor Jiajun Zhang
Jiajun Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240166105Abstract: The application relates to a seat assembly, a trim cover assembly, and a method of assembling. An assembly is provided with a seat member comprising a seating surface with a groove, a first trim layer, a second trim layer attached to the first trim layer, and one or more retaining members attached to the second trim layer. The second trim layer is positioned between the first trim layer and the one or more retaining members. The one or more retaining members are received within the groove, with the one or more retaining members connecting the first trim layer to the seat member. A trim cover assembly, and a method are also provided. In various non-limiting examples, the trim assembly may provide the desired shape of the seat, maintain durability and appearance, prevent looseness, and conceal the attachment of the retaining member.Type: ApplicationFiled: August 21, 2023Publication date: May 23, 2024Applicant: Lear CorporationInventors: Huaying ZHANG, Jiajun LI, Yong YANG, Chandrashekar SIMHA
-
Patent number: 11970502Abstract: The present invention discloses macrocyclic compounds of Formula (I), and pharmaceutically acceptable salts, thereof: which inhibit coronavirus replication activity. The invention further relates to pharmaceutical compositions comprising a compound of Formula (I) or a pharmaceutically acceptable salt thereof, and methods of treating or preventing a coronavirus infection in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of Formula (I) or a pharmaceutically acceptable salt thereof.Type: GrantFiled: May 3, 2022Date of Patent: April 30, 2024Assignee: Enanta Pharmaceuticals, Inc.Inventors: Jiajun Zhang, Xiaowen Peng, Yat Sun Or
-
Publication number: 20240130276Abstract: A riding mowing device includes a seat used for a user to sit on and including a seat cushion and a backrest; a frame for supporting the seat; a cutting assembly including a cutting deck and a mowing element for mowing grass, where the mowing element is at least partially accommodated in the cutting deck, and the cutting assembly is mounted to the frame; a traveling assembly for driving the riding mowing device to travel; a control circuit board for controlling at least the cutting assembly and the traveling assembly; and a power supply assembly for supplying power to at least the cutting assembly and the traveling assembly. At least part of the control circuit board is disposed between the seat and the power supply assembly.Type: ApplicationFiled: December 11, 2023Publication date: April 25, 2024Inventors: Li Li, Tianfang Wei, Fan Gao, Liang Chen, Haishen XU, Ming Gao, Min Zhang, Tao Zhang, Jiajun Huang, Yunfei Gao
-
Publication number: 20240132512Abstract: The present invention features crystalline forms of Compound I, including polymorphs and pseudopolymorphs, which are useful in the preparation of pharmaceutical compositions.Type: ApplicationFiled: October 5, 2023Publication date: April 25, 2024Inventors: Kaicheng Zhu, Tao Wang, Joseph Helble, Anthony Toto, Jiajun Zhang, George G. Wu, Yat Sun Or
-
Publication number: 20240097456Abstract: A charging system includes at least one first charging device and at least one second charging device that are cascaded. The first charging device includes at least one first accommodation portion for mounting a first energy storage device and a connecting port for connecting the second charging device or the first charging device. The second charging device includes at least one second accommodation portion for mounting a second energy storage device and a connecting port for connecting the first charging device or the second charging device. The first accommodation portion and the second accommodation portion have different shapes or dimensions.Type: ApplicationFiled: November 28, 2023Publication date: March 21, 2024Inventors: Zhengzheng Li, Zheng Geng, Zhijian Lu, Corey Berman, Yiwen XIAO, Jiajun Tong, He Huang, Yuexiang Zhang, Yafei Cao
-
Publication number: 20240097455Abstract: A charging system includes at least one first charging device and at least one second charging device that are cascaded. The first charging device includes at least one first accommodation portion for mounting a first energy storage device and a connecting port for connecting the second charging device or the first charging device. The second charging device includes at least one second accommodation portion for mounting a second energy storage device and a connecting port for connecting the first charging device or the second charging device. The first accommodation portion and the second accommodation portion have different shapes or dimensions.Type: ApplicationFiled: November 28, 2023Publication date: March 21, 2024Inventors: Zhengzheng Li, Zheng Geng, Zhijian Lu, Corey Berman, Yiwen XIAO, Jiajun Tong, He Huang, Yuexiang Zhang, Yafei Cao
-
Publication number: 20240080134Abstract: A method, circuit, audio playback device, and system of sending and receiving Bluetooth packet loss data is disclosed. The method includes: step S100, receiving a forwarding request sent by a second audio playback device in a receiving state; step S200, monitoring the retransmission information of an audio source device retransmitting current audio data on Link 1 according to the forwarding request; step S300, determining whether the retransmission information is monitored; step S400, switching from the receiving state to a sending state; and step S500, forwarding the current audio data to the second audio playback device through Link 2 in accordance with the time sequence of the audio source device retransmitting the current audio data. The signal can be provided to the second audio playback device from different locations.Type: ApplicationFiled: November 10, 2023Publication date: March 7, 2024Inventors: Jiajun Zhu, Haitao Huang, Qiming Zhang, Xiangjun Hu, Guangjun Luo, Ziming Huang, Xin Yu
-
Publication number: 20240080663Abstract: One aspect provides a system and method for provisioning an access point (AP) in a wireless mesh network. During operation, a controller can obtain a set of published global encryption parameters comprising a master public key, apply an identity-based encryption (IBE) scheme to encrypt a configuration message based at least on the master public key, and transmit the encrypted configuration message to a proxy device, which forwards the encrypted configuration message to the AP. The proxy device is coupled to the controller via a previously established secure communication channel and coupled to the AP via an open communication channel. The AP can decrypt the encrypted configuration message using an AP-specific secret key generated based on a unique identifier of the AP and a master private key corresponding to the master public key, thereby facilitating provisioning of the AP based on the configuration message.Type: ApplicationFiled: September 2, 2022Publication date: March 7, 2024Inventors: Jiajun Huang, Xiong Zhang, Chao Guo
-
Patent number: 11919422Abstract: A vehicle braking energy recovering method includes obtaining current location information of a vehicle, determining a current road scenario based on the current location information of the vehicle, determining the current road scenario based on a mapping relationship between a road scenario and a weight, determining a safe distance and a safe speed of the vehicle based on the weight, determining a target torque based on the safe distance and the safe speed of the vehicle, and controlling, based on the target torque, a motor of the vehicle to recover braking energy.Type: GrantFiled: February 16, 2022Date of Patent: March 5, 2024Assignee: HUAWEI TECHNOLOGIES CO., LTD.Inventors: Zuqi Liu, Jianfeng Zheng, Jinbo Ma, Jiajun Huang, Wei Zhang
-
Patent number: 11912714Abstract: The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, thereof: which inhibit coronavirus replication activity. The invention further relates to pharmaceutical compositions comprising a compound of Formula (I) or a pharmaceutically acceptable salt thereof, and methods of treating or preventing a coronavirus infection in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of Formula (I) or a pharmaceutically acceptable salt thereof.Type: GrantFiled: November 9, 2022Date of Patent: February 27, 2024Assignee: Enanta Pharmaceuticals, Inc.Inventors: Hui Cao, Wei Li, Xuri Gao, Jiajun Zhang, Xiaowen Peng, Jorden Kass, Ruichao Shen, Guoqiang Wang, Yat Sun Or
-
Patent number: 11913854Abstract: A method and a system for fault diagnosis with small samples of power equipment based on virtual and real twin spaces are disclosed, which belong to the field of fault diagnosis of power equipment. The method includes: test samples containing different locations, types and severity levels of fault of power equipment are acquired to form a real physical space; a virtual mirror space is acquired by simulation according to a simulation model of the equipment to be diagnosed; the training set in the real physical space is spatially integrated with the sample set in the virtual mirror space to obtain a training sample set in the twin spaces; the training sample set in the twin spaces serves as the supplement to the training set in the real physical space, and the fault type and fault location serve as diagnostic labels to be input to the deep neural network for training.Type: GrantFiled: December 17, 2020Date of Patent: February 27, 2024Assignee: WUHAN UNIVERSITYInventors: Yigang He, Jiajun Duan, Xiaoxin Wu, Liulu He, Hui Zhang, Guolong Shi
-
Publication number: 20230331734Abstract: The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, thereof: which inhibit picornavirus, norovirus or coronavirus replication activity. The invention further relates to pharmaceutical compositions comprising a compound of Formula (I) or a pharmaceutically acceptable salt thereof, and methods of treating or preventing a virus infection in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of Formula (I) or a pharmaceutically acceptable salt thereof.Type: ApplicationFiled: April 4, 2023Publication date: October 19, 2023Inventors: Hui Cao, Jiajun Zhang, Xuechao Xing, Matthew C. Rhodes, Xuri Gao, Wei Li, Yat Sun Or
-
Publication number: 20230295175Abstract: The present invention relates to processes for preparing a compound of Formula (A): or a pharmaceutically acceptable salt or solvate thereof. Compound of Formula (A) and pharmaceutical compositions are useful as SARS-CoV-2 3CL pro inhibitors.Type: ApplicationFiled: March 17, 2023Publication date: September 21, 2023Inventors: Kaicheng Zhu, Tao Wang, Xin Zhang, Xiaowen Peng, Ruichao Shen, Jiajun Zhang, Wei Li, Hui Cao, Xuri Gao, Guoqiang Wang, George G. Wu, Yat Sun Or
-
Patent number: 11760755Abstract: The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, thereof: which inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV life cycle of the hepatitis B virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HBV infection. The invention also relates to methods of treating an HBV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.Type: GrantFiled: June 4, 2020Date of Patent: September 19, 2023Assignee: Enanta Pharmaceuticals, Inc.Inventors: Yao-Ling Qiu, Xiaowen Peng, Xuri Gao, Wei Li, Hui Cao, Byung-Chul Suh, Jorden Kass, Jiajun Zhang, Yat Sun Or
-
Publication number: 20230234922Abstract: The present invention relates to processes for preparing a Compound (1): or a pharmaceutically acceptable salt or solvate thereof. Compound (1) is useful as in many pharmaceutical agents, especially is useful as key intermediate in the synthesis of certain SARS-CoV-2 3CLpro inhibitors.Type: ApplicationFiled: January 10, 2023Publication date: July 27, 2023Inventors: Kaicheng Zhu, Tao Wang, Jiajun Zhang, Hui Cao, Ruichao Shen, Guoqiang Wang, George G. Wu, Yat Sun Or
-
Publication number: 20230159546Abstract: The present invention discloses compounds of Formula (Ia), and pharmaceutically acceptable salts thereof: which inhibit coronavirus replication activity. The invention further relates to pharmaceutical compositions comprising a compound of Formula (Ia) or a pharmaceutically acceptable salt thereof, and methods of treating or preventing a coronavirus infection in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of Formula (Ia) or a pharmaceutically acceptable salt thereof.Type: ApplicationFiled: November 17, 2022Publication date: May 25, 2023Inventors: Jorden Kass, Wei Li, Hui Cao, Jiajun Zhang, Xuri Gao, Xiaowen Peng, Ruichao Shen, Guoqiang Wang, Yat Sun Or
-
Publication number: 20230151019Abstract: The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, thereof: which inhibit coronavirus replication activity. The invention further relates to pharmaceutical compositions comprising a compound of Formula (I) or a pharmaceutically acceptable salt thereof, and methods of treating or preventing a coronavirus infection in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of Formula (I) or a pharmaceutically acceptable salt thereof.Type: ApplicationFiled: November 9, 2022Publication date: May 18, 2023Inventors: Hui Cao, Wei Li, Xuri Gao, Jiajun Zhang, Xiaowen Peng, Jorden Kass, Ruichao Shen, Guoqiang Wang, Yat Sun Or
-
Publication number: 20230122228Abstract: The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, thereof: which inhibit coronavirus replication activity. The invention further relates to pharmaceutical compositions comprising a compound of Formula (I) or a pharmaceutically acceptable salt thereof, and methods of treating or preventing a coronavirus infection in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of Formula (I) or a pharmaceutically acceptable salt thereof.Type: ApplicationFiled: April 14, 2022Publication date: April 20, 2023Inventors: Ruichao Shen, Yong He, Xuechao Xing, Matthew C. Rhodes, Joseph D. Panarese, Samuel Bartlett, Wei Li, Hui Cao, Jiajun Zhang, Xiaowen Peng, Guoqiang Wang, Yat Sun Or
-
Publication number: 20230115107Abstract: The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, thereof: which inhibit coronavirus replication activity. The invention further relates to pharmaceutical compositions comprising a compound of Formula (I) or a pharmaceutically acceptable salt thereof, and methods of treating or preventing a coronavirus infection in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of Formula (I) or a pharmaceutically acceptable salt thereof.Type: ApplicationFiled: April 14, 2022Publication date: April 13, 2023Inventors: Xuri Gao, Wei Li, Jiajun Zhang, Xiaowen Peng, Hui Cao, Jorden Kass, Ruichao Shen, Guoqiang Wang, Yat Sun Or
-
Publication number: 20230103494Abstract: The present invention discloses compounds of Formula (Ia), and pharmaceutically acceptable salts, thereof: which inhibit coronavirus replication activity. The invention further relates to pharmaceutical compositions comprising a compound of Formula (Ia) or a pharmaceutically acceptable salt thereof, and methods of treating or preventing a coronavirus infection in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of Formula (Ia) or a pharmaceutically acceptable salt thereof.Type: ApplicationFiled: November 22, 2021Publication date: April 6, 2023Inventors: Guoqiang Wang, Ruichao Shen, Yong He, Jun Ma, Xuechao Xing, Hui Cao, Xuri Gao, Xiaowen Peng, Jiang Long, Wei Li, Jiajun Zhang, Joseph D. Panarese, Nathaniel Thomas Kenton, Samuel Bartlett, Yat Sun Or